Curative Biotechnology Inc (CUBT)

[tdgnts]

Even on a fully diluted basis the market cap here is very small with the potential of the pipeline.

Insiders preferred shares will need to convert before the uplist. Most insiders need significant appreciation before any of their warrants will be worthwhile.

Senior leadership has agreed to a share lockup.

At the end of the day insiders need the price to appreciate in the long-term.

It seems pretty evident to me leadership has a plan for share price appreciation with the first step being an uplist.

I suggest everyone reads the S-1 and makes their own informed decisions.